Therefore, driven by the growing demand for cell and gene therapies, and the active ongoing efforts of industry stakeholders, the non-viral transfection reagents and systems market is anticipated to grow at a steady pace in the foreseen future.
The future opportunity within the non-viral transfection reagents and systems market has been analyzed across the following segments:
- Non-Viral Based Transfection Methods
- Chemical-based Methods
- Physical-based Methods
- Other Methods
- End-Users
- Academic And Research Institutions
- Stem Pharmaceutical Companies
- Other End-Users
- Area of Application
- Clinical Applications
- Research Applications
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
The “Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035” report features the following companies, which we identified to be key players in this domain:
- BEX
- Bio-Rad Laboratories
- BTX
- Celsion Corporation
- Genprex
- Inovio Pharmaceuticals
- MaxCyte
- MilliporeSigma
- NepaGene
- OZ Biosciences
- Thermo Fisher Scientific
Table of Contents
- Preface
- Executive Summary
- Introduction
- Non-Viral Transfection Reagents: Market Landscape
- Electroporation-Based Transfection Systems: Market Landscape
- Other Non-Viral Transfection Systems: Market Landscape
- Company Competitiveness Analysis
- Technology Competitiveness Analysis
- Company Profiles
- Potential Strategic Partners
- Big Pharma Initiatives
- Patent Analysis
- Publication Analysis
- Roots Analysis Pricing Strategy Framework
- Market Sizing and Opportunity Analysis
- Executive Insights
- Conclusion
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/non-viral-transfection/307.html
Learn from experts: do you know about these emerging industry trends?
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Digital Therapies: The “Digital Pills” of current generation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
